DexCom, Inc. (DXCM): A Bear Case Theory

We came across a bearish thesis on DexCom, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on DXCM. DexCom, Inc.’s share was trading at $65.41 as of October 15th. DXCM’s trailing and forward P/E were 46.79 and 25.64 respectively according to Yahoo Finance.

5 Countries With The Highest Rate Of Diabetes

Hunterbrook Media’s investigation reveals severe safety, operational, and financial concerns at Dexcom (DXCM), particularly surrounding its G7 continuous glucose monitor (CGM). After...